Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CETP | P11597 | 2/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11746154 | 0.92 | TSHR (0.50) | TSHRLMNAKDM4EL3MBTL1POLB | |
| SCHEMBL11741582 | 0.82 | USP2 (0.43) | TSHRLMNAKDM4EL3MBTL1POLB | |
| SCHEMBL11504772 | 0.82 | KDM4E (0.45) | TSHRLMNAKDM4EL3MBTL1POLB | |
| SCHEMBL3537961 | 0.82 | CYP2C19 (0.41) | TSHRLMNANR1H2NR1H3ALDH1A1 | |
| SCHEMBL18995910 | 0.81 | CETP (0.47) | LMNAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL8959067 | 0.81 | KDM4E (0.44) | TSHRLMNAKDM4EL3MBTL1POLB | |
| SCHEMBL20717114 | 0.81 | LMNA (0.45) | TSHRLMNANR1H2NR1H3ALDH1A1 | |
| SCHEMBL11675994 | 0.81 | LTA4H (0.43) | LMNAKDM4EL3MBTL1POLBALDH1A1 | |
| SCHEMBL1632396 | 0.80 | TDP1 (0.55) | TSHRLMNAKDM4EL3MBTL1NR1H2 | |
| SCHEMBL18177923 | 0.80 | TSHR (0.48) | TSHRLMNAKDM4EL3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1812401-B1 | METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES | BASF SE (DE) | 2015-06-24 | — | — | EP | disclosed |
| US-8026295-B2 | Curable acrylic mixture including a hindered amine light stabilizer having a 4-Amino-2,2,6,6-tetramethylpiperidin-1 oxyl moiety linked to an acrylic moiety so as to polymerize with the primary resin | DENTSPLY INTERNATIONAL, INC. (US) | 2011-09-27 | — | — | US | disclosed |
| US-8026295-B2 | Curable acrylic mixture including a hindered amine light stabilizer having a 4-Amino-2,2,6,6-tetramethylpiperidin-1 oxyl moiety linked to an acrylic moiety so as to polymerize with the primary resin | DENTSPLY INTERNATIONAL, INC. (US) | 2011-09-27 | — | — | US | disclosed |
| US-7799920-B2 | Method for producing perylene-3,4-dicarboxylic acid imides | BASF AKTIENGESELLSCHAFT (DE) | 2010-09-21 | — | — | US | disclosed |
| US-20080114170-A1 | Method For Producing Perylene-3,4-Dicarboxylic Acid Imides | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-15 | — | — | US | disclosed |
| US-20080103229-A1 | Dental composition with improved light stability | WALZ UWE | 2008-05-01 | — | — | US | disclosed |
| US-20080103229-A1 | Dental composition with improved light stability | WALZ UWE | 2008-05-01 | — | — | US | disclosed |
| EP-1812401-A1 | METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006050860-A1 | METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-18 | — | — | WO | disclosed |
| US-3993619-A | AZO DYES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103229-A1 | Dental composition with improved light stability | RARA, MAP1LC3A, MAP1LC3C | TSHR 3729/4885LMNA 1016/4885KDM4E 2354/4885 |
| US-20080114170-A1 | Method For Producing Perylene-3,4-Dicarboxylic Acid Imides | CPNE4, IDH3A, RPL23A | TSHR 2288/4885LMNA 642/4885KDM4E 2062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.